Dr. Reddy’s Laboratories has launched Colesevelam HCl Tablets, USP, a therapeutic equivalent generic version of WELCHOL (colesevelam HCl) Tablets in the United States market approved by the U.S. Food and Drug Administration (FDA).
The WELCHOL brand and generic had U.S. sales of approximately $471 million MAT for the most recent twelve months ending in August 2018 according to IMS Health.
Dr. Reddy’s Colesevelam Hydrochloride Tablets is available in 625 mg with 180 count bottle size.
WELCHOL is a registered trademark of Daiichi Sankyo.